Momenta Pharmaceuticals, Inc.
(NASDAQ : MNTA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. 0.71%579.812.7%$671.17m
AMGNAmgen, Inc. -0.36%227.161.3%$582.50m
GILDGilead Sciences, Inc. 0.20%60.791.0%$581.98m
VRTXVertex Pharmaceuticals, Inc. 0.71%211.581.9%$512.07m
ILMNIllumina, Inc. -0.73%323.553.5%$494.75m
MRNAModerna, Inc. -0.44%70.530.0%$473.04m
ARRYArray BioPharma Inc. -4.42%42.0014.2%$403.84m
IMMUImmunomedics, Inc. 0.00%87.8611.0%$392.45m
NVAXNovavax, Inc. -0.49%93.1396.5%$309.58m
ALXNAlexion Pharmaceuticals, Inc. 1.62%121.612.0%$277.29m
BIIBBiogen, Inc. -0.68%265.001.7%$264.24m
EXASEXACT Sciences Corp. 2.44%109.7020.7%$241.86m
BNTXBioNTech SE 2.70%88.690.0%$221.27m
SRNESorrento Therapeutics, Inc. -2.42%8.081.4%$162.95m
SGENSeagen Inc. -1.86%196.926.0%$157.61m

Company Profile

Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.